Grassley, Baucus Question Avandia Advisory Committee

Drug Industry Daily
A A
Sens. Chuck Grassley (R-Iowa) and Max Baucus (D-Mont.) sent a letter to FDA Commissioner Andrew von Eschenbach questioning the agency’s upcoming review of Avandia’s safety as well as the alleged treatment of a senior FDA official who raised concerns about the drug.

To View This Article:

Login

Subscribe To Drug Industry Daily